Pharmaceuticals
Sihuan Pharmaceutical (0460) Won the Fifth "Listed Enterprises of the Year 2020" Presented by Bloomberg Businessweek/Chinese Edition
HONG KONG, Dec. 3, 2020 /PRNewswire/ -- Bloomberg Businessweek/Chinese Edition announced thatSihuan Pharmaceutical Holdings Group Ltd. (0460.HK) won the fifth "Listed Enterprises of the Year 2020". The event received enthusiastic support with enterprises from a wide range of industries participat...
2020-12-03 10:36
8154
WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth of Expertise in Facilitating Early-stage Innovation and Clinical Research
The company accelerated clients' R&D and ensured agility by leveraging a global footprint, keen customer focus, and customized solutions. LONDON, Dec. 2, 2020 /PRNewswire/ -- Based on its recent analysis of the global contract research organization (CRO) market, Frost & Sullivan recognizes WuXi A...
2020-12-02 22:00
1521
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation
MUNICH and SHANGHAI, Dec. 2, 2020 /PRNewswire/ -- Tubulis, WuXi STA and WuXi Biologics today announced a strategic collaboration to manufacture and advance Tubulis' next generation antibody-drug conjugates (ADCs) towards IND-enabling studies. Tubulis has developed a dual platform approach to gene...
2020-12-02 19:00
2005
Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application
HONG KONG, Dec. 2, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Pharmaceutical...
2020-12-02 18:35
10331
Central IVF Limited's Egg Donation Service Recognized as One of The Most Reputable in Australia
LONDON, Dec. 2, 2020 /PRNewswire/ -- Central IVF Limited has gone through a rebranding process emphasizing its leadership in the field of Egg Donation and representing the launching of its Donor Sperm service toAustralia. Donor Egg service has been rebranded as Central Egg Bank (CEB) and Donor S...
2020-12-02 16:44
1323
Ascentage Pharma Announces Clearances in China and the US for the Phase IIa Study of APG-115 Single Agent or in Combination with APG-2575 for the Treatment of Relapsed or Refractory T-cell Prolymphocytic Leukemia
SUZHOU, China and ROCKVILLE, Md., Dec. 2, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eval...
2020-12-02 08:09
2444
RxLogix Acclaimed by Frost & Sullivan for its Best-in-class Pharmacovigilance Solution, PV Intake & Processing
SANTA CLARA, Calif., Dec. 1, 2020 /PRNewswire/ -- Based on its recent analysis of the global pharmacovigilance (PV) automation software market, Frost & Sullivan recognizesRxLogix Corporation with the 2020 Global Product Leadership Award for its PV Intake & Processing (PVIP) solution. The Product ...
2020-12-01 21:00
1482
CSafe Global Launches an Industry First: Real-Time Shipment Visibility
CSafe Global continues to focus on innovating temperature-controlled container solutions with the launch of 24/7 real-time shipment visibility. DAYTON, Ohio, Dec. 1, 2020 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of lif...
2020-12-01 21:00
2344
AGC Biologics to Expand Biopharmaceutical CDMO Capacity
Doubling the production capacity at its site in Denmark to address strong demand SEATTLE, Dec. 1, 2020 /PRNewswire/ -- AGC Biologics announced that it will increase the production capacity of itsCopenhagen facility. AGC Biologics will construct a new building on land adjacent to its currentCopenh...
2020-12-01 05:55
2011
ORTHO Optix™ Reader Now Available in CE Mark Countries, Completes Transfusion Medicine Portfolio
RARITAN, N.J., Dec. 1, 30, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the CE Mark availability of the semi-automated ORTHO Optix™ Reader, which allows lo...
2020-12-01 00:57
1367
Population Council and Duchesnay Announce New International License Agreement for ANNOVERA®
NEW YORK and BLAINVILLE, QC, Nov. 30, 2020 /PRNewswire/ -- Today the Population Council and Duchesnay announce an exclusive license agreement to make ANNOVERA® (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive fully under a woman's control to protect aga...
2020-11-30 23:00
2333
RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19
RedHill adds two more manufacturing partners, both U.S.-based, for large-scale manufacturing of opaganib, in preparation for potential emergency use applications as early as Q1/2021 The new collaborations follow recently announced collaborations with European and Canadian manufacturers U.S. Pha...
2020-11-30 10:45
3055
Gilead Sciences' Pulse Survey Highlights Majority of People Living with HIV, Individuals at Risk and HIV Care Prescribers in Asia Pacific Experience Disruptions in HIV Care During COVID-19 Pandemic
HONG KONG, Nov. 30, 2020 /PRNewswire/ -- Gilead Sciences, Inc. today announced findings from a pulse survey conducted to evaluate the impact of the COVID-19 pandemic on the access and delivery of care in HIV, which includes testing, treatment and prevention, inAsia Pacific. The survey revealed ...
2020-11-30 10:40
6118
Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology
SUZHOU, China and ROCKVILLE, Md., Nov. 30, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced it has entered into an ag...
2020-11-30 08:09
2376
Gannex Appoints Former Takeda Head of Liver Disease Clinical Development Melissa Palmer, MD as Chief Medical Officer
SHANGHAI, Nov. 30, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announced today that Melissa Palmer, MD, an internationally renowned Hepatologist, will join the Compa...
2020-11-30 08:00
2821
Nanoform Finland Plc, Interim Report January - September 2020, November 27th, 2020 at 08:00 a.m. Finnish time
HELSINKI, Nov. 27, 2020 /PRNewswire/ -- Strong momentum continues: first GMP campaign initiated, first dosing in humans to start before year-end, all near-term business targets set out in IPO to be achieved ahead of schedule, new global major pharma client signed, two new PoC projects started, on...
2020-11-27 14:30
5905
European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations
DARMSTADT, Germany, Nov. 27, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) ...
2020-11-27 08:42
2450
Luye Pharma and Distriphil Enter Exclusive Distribution Partnership in the Philippines with Joint Commitment to Raising Mental Health Awareness
* Luye Pharma grants Distriphil exclusive distribution and marketing rights for Seroquel® and Seroquel XR® in the Philippines * Two companies pledge to make joint effort to raise awareness of mental health issues as part of the "We Care About Mental Health" initiative SHANGHAI, Nov. 26, 2020 ...
2020-11-26 16:44
5822
Interim report, May-October 2020/21
STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- In Elekta's second quarter, we managed to perform better than the overall radiotherapy market both in terms of orders and revenue despite continuous challenging circumstances. We also improved margins and stabilized cash flow. The launch of our new Harmony...
2020-11-26 15:01
6559
Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for the Treatment of Myelodysplastic Syndrome
SHANGHAI and HONG KONG, Nov. 26, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", HKSE stock code: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-inclass therapeutics in hematolog...
2020-11-26 14:04
5702
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 317 media titles]
2024-06-25 21:00
THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15653
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
13314
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9440
